or
Bookmark and Share
Nontypeable Haemophilus influenzae virulence factors
   
Document Number
US Patent 7306805
Issued Date
December 11, 2007
Link
Inventors
Map
Abstract
The invention relates to a mutation within the sap operon of an avirulent clone of a nontypeable strain of Haemophilus influenzae (NTHi). The invention also relates to the NTHi sap operon genes and the polypeptides encoded by these polynucleotide sequences. The invention also relates to a novel 110 kDa NTHi outer membrane protein and the polynucleotide that encodes this outer membrane protein. Methods of screening for NTHi infection, and treating and preventing NTHi related disorders are also contemplated.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Published
December 11, 2007
Application Number
10/807,746
Filed
March 24, 2004
US Classification
424/190.1   424/185.1 424/256.1 530/300 530/350
Int'l Classification
A61K   39/02   (20060101)  
Parent Case
RELATED APPLICATIONS The present application claims priority benefit from U.S. Provisional Application 60/458,234 filed Mar. 27, 2003 which is incorporated herein by reference in its entirety.
USPTO Field of Search
424/256.1   424/185.1   424/190.1   530/300   530/350  
Related Patents
7449178 - Attenuated gram negative bacteria - Owned by Merial Limited (Duluth, GA)

Disclosed and claimed are a mutant of a gram negative bacterium, wherein said bacterium has at least one mutation in a nucleotide sequence which codes for a polypeptide having an identity which is equal or more than 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% with an amino acid sequence coded by a nucleotide sequence selected from the group consisting of nucleotide sequences identified SEQ ID NO: 2, 6, 9, 12, 16, 19, 22, 25, 28, 31, 34, 37, 40, 43, 46, 49, 52, 55, 58, 61, 64, 67, 70, 75, 78, 81, 84, 87, 90, 93; said mutation resulting in attenuated virulence of the bacterium. Immunogenic compositions and vaccines containing such a mutant are also disclosed and claimed.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us